It is noteworthy to mention that most of the identified autoantibody responses in cancer are also reported in autoimmune diseases, such as auaoantibody responses to actin (77, 78), tubulin (79–81) and RUVBL2 (82). This evidence concerns the gene RUVBL2 and autoimmune disease.